Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
Background: To compare the efficacy and safety of novel oral anticoagulants (NOACs) and vitamin K antagonists (VKAs) in nonvalvular atrial fibrillation (NVAF) patients with left atrial/left atrial thrombosis through a systematic review and meta-analysis....
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-01-01
|
| Series: | Reviews in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM26055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586533753847808 |
|---|---|
| author | Guan-lian Mo Jing Wen Yu-yu Ye Yong-qi Lu Tian-ming Gan Ying-jie Yang Jin-yi Li |
| author_facet | Guan-lian Mo Jing Wen Yu-yu Ye Yong-qi Lu Tian-ming Gan Ying-jie Yang Jin-yi Li |
| author_sort | Guan-lian Mo |
| collection | DOAJ |
| description | Background: To compare the efficacy and safety of novel oral anticoagulants (NOACs) and vitamin K antagonists (VKAs) in nonvalvular atrial fibrillation (NVAF) patients with left atrial/left atrial thrombosis through a systematic review and meta-analysis. Methods: The CBM (China Biology Medicine disc), CNKI (China National Knowledge Infrastructure), VIP (Chinese Technology Periodical Database), Wanfang, PubMed, Embase, Cochrane Library, and Web of Science databases were searched for relevant studies from their inception to June 30, 2022. Results: Twelve articles (eight cohort studies and four randomized controlled trials) involving 982 patients were included. Meta-analysis showed that NOACs had a significantly higher thrombolysis rate than VKAs (78.0% vs. 63.5%, odds ratio (OR) = 2.32, 95% confidence interval (CI) 1.71 to 3.15, p < 0.0001). Subgroup analysis revealed rivaroxaban to be more effective than VKAs, whereas there was no significant difference between dabigatran and apixaban. There were no significant differences in embolic events, bleeding, or all-cause mortality. Thrombus resolution analysis showed higher left ventricular end-diastolic diameter and smaller left atrial diameter in the effective group than in the ineffective group. Conclusions: NOACs are more effective in thrombolysis than VKAs in NVAF patients with left atrial thrombosis, and there is no increased risk of adverse events compared with VKAs. |
| format | Article |
| id | doaj-art-c64e0926433f4f108e30e46dc33a1c40 |
| institution | Kabale University |
| issn | 1530-6550 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Reviews in Cardiovascular Medicine |
| spelling | doaj-art-c64e0926433f4f108e30e46dc33a1c402025-01-25T10:41:20ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-01-012612605510.31083/RCM26055S1530-6550(24)01634-XEfficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-AnalysisGuan-lian Mo0Jing Wen1Yu-yu Ye2Yong-qi Lu3Tian-ming Gan4Ying-jie Yang5Jin-yi Li6Department of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaDepartment of Cardiology, Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, ChinaBackground: To compare the efficacy and safety of novel oral anticoagulants (NOACs) and vitamin K antagonists (VKAs) in nonvalvular atrial fibrillation (NVAF) patients with left atrial/left atrial thrombosis through a systematic review and meta-analysis. Methods: The CBM (China Biology Medicine disc), CNKI (China National Knowledge Infrastructure), VIP (Chinese Technology Periodical Database), Wanfang, PubMed, Embase, Cochrane Library, and Web of Science databases were searched for relevant studies from their inception to June 30, 2022. Results: Twelve articles (eight cohort studies and four randomized controlled trials) involving 982 patients were included. Meta-analysis showed that NOACs had a significantly higher thrombolysis rate than VKAs (78.0% vs. 63.5%, odds ratio (OR) = 2.32, 95% confidence interval (CI) 1.71 to 3.15, p < 0.0001). Subgroup analysis revealed rivaroxaban to be more effective than VKAs, whereas there was no significant difference between dabigatran and apixaban. There were no significant differences in embolic events, bleeding, or all-cause mortality. Thrombus resolution analysis showed higher left ventricular end-diastolic diameter and smaller left atrial diameter in the effective group than in the ineffective group. Conclusions: NOACs are more effective in thrombolysis than VKAs in NVAF patients with left atrial thrombosis, and there is no increased risk of adverse events compared with VKAs.https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM26055new oral anticoagulantsvitamin k antagonistatrial fibrillationthrombosismeta-analysis |
| spellingShingle | Guan-lian Mo Jing Wen Yu-yu Ye Yong-qi Lu Tian-ming Gan Ying-jie Yang Jin-yi Li Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis Reviews in Cardiovascular Medicine new oral anticoagulants vitamin k antagonist atrial fibrillation thrombosis meta-analysis |
| title | Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis |
| title_full | Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis |
| title_fullStr | Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis |
| title_short | Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis |
| title_sort | efficacy and safety of new oral anticoagulants versus warfarin in the resolution of atrial fibrillation with left atrial left atrial appendage thrombus a systematic review and meta analysis |
| topic | new oral anticoagulants vitamin k antagonist atrial fibrillation thrombosis meta-analysis |
| url | https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM26055 |
| work_keys_str_mv | AT guanlianmo efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT jingwen efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT yuyuye efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT yongqilu efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT tianminggan efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT yingjieyang efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis AT jinyili efficacyandsafetyofneworalanticoagulantsversuswarfarinintheresolutionofatrialfibrillationwithleftatrialleftatrialappendagethrombusasystematicreviewandmetaanalysis |